The chemical class of potential PCDHGC5 activators primarily consists of compounds that influence cell adhesion, signaling pathways related to adhesion, and cytoskeletal dynamics. These activators and inhibitors operate through diverse mechanisms, such as modulation of calcium levels, inhibition of specific signaling pathways like Wnt/β-catenin, and alteration of cytoskeletal regulation. For instance, calcium ionophores and β-catenin inhibitors might indirectly affect PCDHGC5 by altering cell adhesion mechanisms and associated signaling. Rho kinase and Src kinase inhibitors, by modulating cytoskeletal dynamics and adhesion signaling, could influence PCDHGC5's role in cell-cell interactions. N-Cadherin antagonists and Wnt pathway inhibitors like IWP-2 further demonstrate the potential for modulation of cell adhesion and communication processes that could impact PCDHGC5.
Moreover, PI3K and MEK inhibitors, targeting fundamental signaling pathways, and EGFR inhibitors, known for their role in cell adhesion and communication, offer additional avenues for indirectly influencing PCDHGC5 activity. GSK-3 inhibitors, MMP inhibitors, and histone deacetylase inhibitors expand this class by targeting the extracellular matrix dynamics, gene expression regulation, and signaling processes involved in cell adhesion.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophores increase intracellular calcium, crucial for cadherin function, potentially affecting PCDHGC5. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
β-Catenin is involved in cadherin signaling; its inhibitors might influence PCDHGC5 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Rho kinase is involved in cytoskeletal dynamics affecting cell adhesion; inhibitors could impact PCDHGC5. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Src kinase modulates various signaling pathways, including those related to cell adhesion; inhibitors might affect PCDHGC5. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
The Wnt signaling pathway influences cell adhesion and communication; inhibitors could affect PCDHGC5. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K is involved in various cellular processes, including cell adhesion; inhibitors might impact PCDHGC5. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
MEK is part of the MAPK signaling pathway, which can be involved in cell adhesion; inhibitors could influence PCDHGC5. | ||||||
Erlotinib Hydrochloride | 183319-69-9 | sc-202154 sc-202154A | 10 mg 25 mg | $75.00 $121.00 | 33 | |
EGFR signaling can influence cell adhesion mechanisms; inhibitors might affect PCDHGC5 indirectly. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
GSK-3 is involved in Wnt/β-catenin signaling; inhibitors can indirectly impact PCDHGC5. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Matrix metalloproteinases affect the extracellular matrix and cell adhesion; inhibitors might influence PCDHGC5. | ||||||